NDC 0169-4181 – Ozempic
Semaglutide .68 mg/mL · Injection, Solution · Subcutaneous
Product NDC0169-4181
Product details
- Brand name
- Ozempic
- Generic name
- Semaglutide
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- NDA · NDA209637
- Marketed since
- October 7, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- GLP-1 Receptor Agonist
Active ingredients
- Semaglutide .68 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0169-4181-13 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-4181-13) / 3 mL in 1 SYRINGE, PLASTIC (0169-4181-03) | Oct 7, 2022 |
| 0169-4181-97 sample | 1 SYRINGE, PLASTIC in 1 CARTON (0169-4181-97) / 3 mL in 1 SYRINGE, PLASTIC (0169-4181-90) | Oct 7, 2022 |
Other Ozempic products
- 50090-5949 Semaglutide 1.34 mg/mL · Injection, Solution · A-S Medication Solutions
- 50090-6051 Semaglutide 2.68 mg/mL · Injection, Solution · A-S Medication Solutions
- 50090-8027 Semaglutide .68 mg/mL · Injection, Solution · A-S Medication Solutions
- 0169-4130 Semaglutide 1.34 mg/mL · Injection, Solution · Novo Nordisk Pharmaceutical Industries, LP
- 0169-4772 Semaglutide 2.68 mg/mL · Injection, Solution · Novo Nordisk Pharmaceutical Industries, LP
- 0169-1704 Semaglutide 4 mg/1 · Tablet · Novo Nordisk Pharmaceutical Industries, LP
- 0169-1709 Semaglutide 9 mg/1 · Tablet · Novo Nordisk Pharmaceutical Industries, LP
- 0169-1715 Semaglutide 1.5 mg/1 · Tablet · Novo Nordisk Pharmaceutical Industries, LP